FLR vs JBTM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Fluor Corporation exhibits severe operational distress, highlighted by a critical Piotroski F-Score of 0/9, indicating a total lack of improvement in financial health across all measured dimensions. Despite a stable balance sheet with low debt and healthy liquidity ratios, the company is suffering from negative profit and gross margins and a catastrophic recent earnings miss (Actual $-9.87 vs Est $0.36). The combination of declining revenue, massive EPS contraction, and bearish insider selling outweighs the optimistic analyst target prices.
JBTM presents a stark contrast between explosive top-line growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While revenue growth is exceptional at 115.60% YoY and analysts maintain a bullish target price of $183.50, the company is currently struggling with negative profit margins (-1.33%) and negative ROE (-1.65%). Liquidity is a concern with a Quick Ratio of 0.45, and insider sentiment is bearish with significant selling by the CEO and Directors. The stock is a high-growth play with significant underlying financial instability.
Compare Another Pair
Related Comparisons
FLR vs JBTM: Head-to-Head Comparison
This page compares Fluor Corporation (FLR) and JBT Marel Corporation (JBTM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.